Stockreport

Invenra Inc. Announces a Strategic Research Agreement with Astellas Pharma in Therapeutic Bispecific Antibody Discovery [Yahoo! Finance]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF strategic research agreement with Astellas Pharma, a global pharmaceutical company with a vision to turn innovative science into value for patients. This agreement will [Read more]